Episode 32: Precision Medicine in Pharma: Sanofi’s Frank Nestle
The CSO and global head of research explains how Sanofi uses AI to discover and develop targeted therapies.
Why do only 10% of companies succeed with AI? For four years, BCG and MIT SMR have studied corporate adoption of artificial intelligence. The most recent research has found that 90% of organizations do not realize significant financial benefit from the technology. So, what are the other 10% doing right? Each episode of Me, Myself, and AI features a discussion with a leading practitioner helping his or her organization gain measurable value from AI.
Whether they work at a born-digital organization or (more often) a legacy company, our guests all have actionable insights to share. The series covers strategy, deployment, human-and-machine collaboration, and scaling. We also explore what first interested these leaders in AI, how they got to where they are today, and what keeps them excited about their field.
The CSO and global head of research explains how Sanofi uses AI to discover and develop targeted therapies.
A New Home for the World’s Best Tech Talent
BCG X is where tech-build and design talent works with the world’s leading organizations to solve their biggest strategic and technological challenges.